These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6104554)

  • 1. Effects of cardioselective and nonselective beta-blockade on dynamic exercise performance in mildly hypertensive men.
    Leenen FH; Coenen CH; Zonderland M; Maas AH
    Clin Pharmacol Ther; 1980 Jul; 28(1):12-21. PubMed ID: 6104554
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of beta-adrenergic blockade on endurance and short-time performance in respect to individual muscle fiber composition.
    Kaiser P; Rössner S; Karlsson J
    Int J Sports Med; 1981 Feb; 2(1):37-42. PubMed ID: 6120902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical performance and muscle metabolism during beta-adrenergic blockade in man.
    Kaiser P
    Acta Physiol Scand Suppl; 1984; 536():1-53. PubMed ID: 6151777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of beta 1-selective and nonselective beta-adrenoceptor blockade during exercise conditioning in healthy adults.
    McLeod AA; Kraus WE; Williams RS
    Am J Cardiol; 1984 Jun; 53(11):1656-61. PubMed ID: 6375340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Running performance as a function of the dose-response relationship to beta-adrenoceptor blockade.
    Kaiser P
    Int J Sports Med; 1982 Feb; 3(1):29-32. PubMed ID: 6121762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
    Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension.
    Distler A; Keim HJ; Cordes U; Philipp T; Wolff HP
    Am J Med; 1978 Mar; 64(3):446-51. PubMed ID: 25017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise tolerance with nebivolol and atenolol.
    Van Bortel LM; van Baak MA
    Cardiovasc Drugs Ther; 1992 Jun; 6(3):239-47. PubMed ID: 1353367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of beta 1-selective and nonselective beta blockade on blood pressure relative to physical performance in men with systemic hypertension.
    Kaiser P; Hylander B; Eliasson K; Kaijser L
    Am J Cardiol; 1985 Apr; 55(10):79D-84D. PubMed ID: 3993553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of xamoterol, atenolol and propranolol on breathlessness, fatigue and plasma electrolytes during exercise in healthy volunteers.
    Sørensen EV; Jensen HK; Faergeman O
    Eur J Clin Pharmacol; 1991; 41(1):51-5. PubMed ID: 1685993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the cardioselectivity of five beta-adrenoceptor blocking drugs.
    Pringle TH; Riddell JG; Shanks RG
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):228-37. PubMed ID: 2441175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both atenolol and propranolol blunt the fibrinolytic response to exercise but not resting fibrinolytic potential.
    Fernhall B; Szymanski LM; Gorman PA; Kamimori GH; Kessler CM
    Am J Cardiol; 2000 Dec; 86(12):1398-400, A6. PubMed ID: 11113426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioselective and nonselective beta-adrenoceptor blocking drugs in hypertension: a comparison of their effect on blood pressure during mental and physical activity.
    Floras JS; Hassan MO; Jones JV; Sleight P
    J Am Coll Cardiol; 1985 Jul; 6(1):186-95. PubMed ID: 2861218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dual beta-blockade and calcium antagonism on endurance performance.
    Gordon NF; van Rensburg JP; van den Heever DP; Kalliatakis NB; Myburgh DP
    Med Sci Sports Exerc; 1987 Feb; 19(1):1-6. PubMed ID: 2881183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension.
    Epstein SE; LUbbe WF
    S Afr Med J; 1977 Nov; 52(22):875-9. PubMed ID: 343273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute and chronic beta-adrenoceptor blockade on baroreflex sensitivity in humans.
    Floras JS; Jones JV; Hassan MO; Sleight P
    J Auton Nerv Syst; 1988 Dec; 25(2-3):87-94. PubMed ID: 2906953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA
    Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of beta-adrenergic blockade on biochemical and metabolic response to exercise.
    Opie LH
    Am J Cardiol; 1985 Apr; 55(10):95D-100D. PubMed ID: 2859797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol.
    Hansson L; Westerlund A; Aberg H; Karlberg BE
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):361-5. PubMed ID: 786662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between beta-blockade, hyporeninaemic and hypotensive effect of two beta-blocking agents.
    Amery A; De Plaen JF; Fagard R; Linjen P; Reybrouck T
    Postgrad Med J; 1976; 52 Suppl 4():102-8. PubMed ID: 9626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.